Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 11.83% | |
| Drug Manufacturers - General | 34.80% | 20.51% | |
| Healthcare Plans | 13.47% | 4.98% | |
| Biotechnology | 11.60% | 5.75% | |
| Medical Devices | 11.52% | 1.41% | |
| Diagnostics & Research | 11.16% | 9.26% | |
| Medical Instruments & Supplies | 6.97% | 17.73% | |
| Medical Care Facilities | 3.29% | 35.69% | |
| Drug Manufacturers - Specialty & Generic | 2.72% | 1.51% | |
| Medical Distribution | 2.21% | 10.38% | |
| Health Information Services | 2.13% | 17.09% | |
| Pharmaceutical Retailers | 0.13% | -59.73% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
--
<= -3
-2
-1
0
1
2
>= 3
Largest Companies in This Sector
View MoreName | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 950.53 | 1,003.10 | 12.27% | Buy | ||||
| 587.13 | 619.83 | 7.77% | Buy | ||||
| 164.61 | 171.47 | 5.68% | Buy | ||||
| 197.44 | 196.64 | 5.00% | Buy | ||||
| 116.27 | 140.31 | 4.23% | Buy | ||||
| 605.59 | 630.67 | 3.32% | Buy | ||||
| 112.70 | 124.04 | 2.81% | Buy | ||||
| 268.07 | 284.85 | 2.78% | Buy | ||||
| 326.78 | 328.50 | 2.52% | Buy | ||||
| 479.19 | 482.39 | 2.44% | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 155.37 | 40.661B | 0.09% | ||
| 284.96 | 21.092B | 0.10% | ||
| 147.88 | 7.976B | 0.45% | ||
| 101.70 | 7.812B | 0.35% | ||
| 57.96 | 4.88B | 0.40% |
Mutual Fund Opportunities
View MoreName | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 236.81 | 48.824B | 0.30% | ||
| 99.87 | 48.824B | 0.30% | ||
| 142.76 | 21.092B | 0.10% | ||
| 102.22 | 15.167B | 0.80% | ||
| 101.89 | 15.167B | 0.80% |
Healthcare Research
View MoreDiscover the Latest Analyst and Technical Research for This Sector
Analyst Report: Tilray Brands, Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
RatingPrice TargetAnalyst Report: McKesson Corporation
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
RatingPrice TargetWeekly Stock List
Vickers Stock Research, a subsidiary of Argus Research Group, analyzes insider trading and institutional stock ownership. Form 13Fs, which institutions must file to report their holdings, are due 45 days after the end of calendar quarters and have come in for 2Q24. We review 13Fs of major institutional investors, including activists, to see what they are buying and to look for trends. Activist investing is now less about generating a short-term return and more about achieving long-term returns through an active management/investor partnership. The stock-market volatility during 2Q gave those institutional investors a chance to buy a dip. Taking a look at the 13Fs from well-known institutional portfolios, we see that the big guns were busy, either adding new holdings or increasing existing holdings. Buying was across a variety of sectors. Based on Vickers data, the following are select purchases made in 2Q by some high-profile money managers. We also list one significant sale (of Apple by Berkshire) and also note if the holding is now 4% or more of the total portfolio.
Daily – Vickers Top Insider Picks for 08/26/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.


















